Related Experiment Videos
Beta-adrenergic receptor binding in frontal cortex from suicide victims
K Y Little1, T B Clark, J Ranc
1Department of Psychiatry, University of North Carolina at Chapel Hill.
Biological Psychiatry
|November 1, 1993
Summary
Beta-adrenergic receptor binding in the brain
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Previous studies show inconsistent findings regarding beta-adrenergic binding in suicide victims.
- Discrepancies may stem from variations in subject diagnoses and drug exposure documentation.
Purpose of the Study:
- To investigate the hypothesis that altered beta-adrenergic binding is linked to depressive disorders in suicide victims.
- To systematically collect diagnostic and symptomatic data for improved study accuracy.
Main Methods:
- Collected standardized diagnostic and symptomatic information from families of 15 suicide victims and 15 matched controls.
- Measured [125I]pindolol binding in frontal cortex tissue samples.
Main Results:
- Significantly lower beta-adrenergic binding was observed in the frontal cortex of suicide victims compared to controls (21.1 +/- 1.1 fmol/mg protein vs. 24.8 +/- 0.8 fmol/mg protein, p < .02).
- No distinct diagnostic subgroup was identified among the suicide victims based on binding levels.
Conclusions:
- This study found reduced beta-adrenergic binding in the frontal cortex of suicide victims.
- Findings suggest a potential link between altered beta-adrenergic pathways and suicide, irrespective of specific diagnostic subgroups within the victims.